Kevin Connors - CUTERA President CEO, Director
| TJ9 Stock | EUR 2.04 0.76 0.00% |
CEO
Mr. Kevin P. Connors is the President Chief Executive Officer Director of Cutera Inc. Prior to founding Cutera from May 1996 to June 1998 Mr. Connors served as President and General Manager of Coherent Medical Group a unit of Coherent Inc. which manufactures lasers optics and related accessories. We believe Mr. Connors qualifications to serve on our Board include his knowledge of and leadership experience in the aesthetic medical equipment industry prior to joining Cutera and the substantial understanding of the Company and its operations that he has gained while serving as President CEO and director of the Company since its inception. since 1998.
| Age | 52 |
| Tenure | 26 years |
CUTERA Leadership Team
Elected by the shareholders, the CUTERA's board of directors comprises two types of representatives: CUTERA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CUTERA. The board's role is to monitor CUTERA's management team and ensure that shareholders' interests are well served. CUTERA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CUTERA's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Clinton Severson, Independent Director | ||
| Daniel Plants, Independent Director | ||
| Ronald Santilli, CFO, Executive Vice President | ||
| James Reinstein, President CEO, Director | ||
| Miguel Pardos, Executive Vice President-International Sales | ||
| Gregory Barrett, Independent Director | ||
| Michael Karavitis, Executive Vice President CTO | ||
| Jerry Widman, Independent Director | ||
| Elisha Finney, Non-Executive Independent Director | ||
| Timothy OShea, Independent Director | ||
| Michael Palumbo, Vice President - Global Services | ||
| Darren Alch, Vice President General Counsel, Secretary | ||
| Kevin Connors, President CEO, Director | ||
| David Apfelberg, Lead Independent Director | ||
| John Mills, Integrated Corporate Relations | ||
| Larry Laber, Executive Vice President-North America Sales |
CUTERA Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CUTERA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Current Valuation | 964.89 M | |||
| Price To Book | 60.58 X | |||
| Price To Sales | 3.59 X | |||
| Revenue | 231.27 M | |||
| EBITDA | 7.24 M | |||
| Net Income | 2.06 M | |||
| Total Debt | 134.24 M | |||
| Cash Flow From Operations | 1.24 M | |||
| Number Of Employees | 16 | |||
| Market Capitalization | 597.68 M |
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in CUTERA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. Note that the CUTERA information on this page should be used as a complementary analysis to other CUTERA's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Complementary Tools for CUTERA Stock analysis
When running CUTERA's price analysis, check to measure CUTERA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CUTERA is operating at the current time. Most of CUTERA's value examination focuses on studying past and present price action to predict the probability of CUTERA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CUTERA's price. Additionally, you may evaluate how the addition of CUTERA to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |